114 related articles for article (PubMed ID: 26747525)
21. Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma.
Liu CJ; Liu TY; Kuo LT; Cheng HW; Chu TH; Chang KW; Lin SC
J Pathol; 2008 Mar; 214(4):489-97. PubMed ID: 18213732
[TBL] [Abstract][Full Text] [Related]
22. Prognostic score including gene mutations in chronic myelomonocytic leukemia.
Itzykson R; Kosmider O; Renneville A; Gelsi-Boyer V; Meggendorfer M; Morabito M; Berthon C; Adès L; Fenaux P; Beyne-Rauzy O; Vey N; Braun T; Haferlach T; Dreyfus F; Cross NC; Preudhomme C; Bernard OA; Fontenay M; Vainchenker W; Schnittger S; Birnbaum D; Droin N; Solary E
J Clin Oncol; 2013 Jul; 31(19):2428-36. PubMed ID: 23690417
[TBL] [Abstract][Full Text] [Related]
23. Pseudogene Transcripts in Head and Neck Cancer: Literature Review and
Carron J; Della Coletta R; Lourenço GJ
Genes (Basel); 2021 Aug; 12(8):. PubMed ID: 34440428
[TBL] [Abstract][Full Text] [Related]
24. Validation of genetic sequence variants as prognostic factors in early-stage head and neck squamous cell cancer survival.
Azad AK; Bairati I; Samson E; Cheng D; Mirshams M; Qiu X; Savas S; Waldron J; Wang C; Goldstein D; Xu W; Meyer F; Liu G
Clin Cancer Res; 2012 Jan; 18(1):196-206. PubMed ID: 22076708
[TBL] [Abstract][Full Text] [Related]
25. Identification of Potential Diagnostic and Prognostic Values of
Li M; Wu F; Zheng Q; Wu Y; Wu Y
DNA Cell Biol; 2020 May; 39(5):909-917. PubMed ID: 32150689
[TBL] [Abstract][Full Text] [Related]
26. Expression and clinical significance of the Kv3.4 potassium channel subunit in the development and progression of head and neck squamous cell carcinomas.
Menéndez ST; Rodrigo JP; Allonca E; García-Carracedo D; Alvarez-Alija G; Casado-Zapico S; Fresno MF; Rodríguez C; Suárez C; García-Pedrero JM
J Pathol; 2010 Aug; 221(4):402-10. PubMed ID: 20593490
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of truncating TP53 mutations in head and neck squamous cell carcinoma.
Lindenbergh-van der Plas M; Brakenhoff RH; Kuik DJ; Buijze M; Bloemena E; Snijders PJ; Leemans CR; Braakhuis BJ
Clin Cancer Res; 2011 Jun; 17(11):3733-41. PubMed ID: 21467160
[TBL] [Abstract][Full Text] [Related]
28. ras mutations and expression in head and neck squamous cell carcinomas.
Yarbrough WG; Shores C; Witsell DL; Weissler MC; Fidler ME; Gilmer TM
Laryngoscope; 1994 Nov; 104(11 Pt 1):1337-47. PubMed ID: 7968162
[TBL] [Abstract][Full Text] [Related]
29. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
[TBL] [Abstract][Full Text] [Related]
30. Omics data-driven analysis identifies laminin-integrin-mediated signaling pathway as a determinant for cell differentiation in oral squamous cell carcinoma.
Kulkarni S; Abdulla R; Jose M; Adyanthaya S; B Rex DA; Patil AH; Pinto SM; Subbannayya Y
Indian J Pathol Microbiol; 2019; 62(4):529-536. PubMed ID: 31611435
[TBL] [Abstract][Full Text] [Related]
31. A comprehensive analysis of prognosis prediction models based on pathway‑level, gene‑level and clinical information for glioblastoma.
Liang R; Wang M; Zheng G; Zhu H; Zhi Y; Sun Z
Int J Mol Med; 2018 Oct; 42(4):1837-1846. PubMed ID: 30015853
[TBL] [Abstract][Full Text] [Related]
32. Carcinogenesis, markers, staging, and prognosis of head and neck cancer.
Schantz SP
Curr Opin Oncol; 1993 May; 5(3):483-90. PubMed ID: 8494909
[TBL] [Abstract][Full Text] [Related]
33. Past and future impact of next-generation sequencing in head and neck cancer.
Sethi N; MacLennan K; Wood HM; Rabbitts P
Head Neck; 2016 Apr; 38 Suppl 1():E2395-402. PubMed ID: 25900457
[TBL] [Abstract][Full Text] [Related]
34. Oxidative Stress Gene Expression Profile Correlates with Cancer Patient Poor Prognosis: Identification of Crucial Pathways Might Select Novel Therapeutic Approaches.
Leone A; Roca MS; Ciardiello C; Costantini S; Budillon A
Oxid Med Cell Longev; 2017; 2017():2597581. PubMed ID: 28770020
[TBL] [Abstract][Full Text] [Related]
35. Stoichioproteomics study of differentially expressed proteins and pathways in head and neck cancer.
Lan Y; Liang Y; Xiao X; Shi Y; Zhu M; Meng C; Yang S; Khan MT; Zhang YJ
Braz J Biol; 2021; 83():e249424. PubMed ID: 34730606
[TBL] [Abstract][Full Text] [Related]
36. Prognostic gene expression signature revealed the involvement of mutational pathways in cancer genome.
Liu H; Li H; Luo K; Sharma A; Sun X
J Cancer; 2020; 11(15):4510-4520. PubMed ID: 32489468
[No Abstract] [Full Text] [Related]
37. RNA sequencing and expression heterogeneity in head and neck cancer.
Parikh AS; Puram SV
Cancer Cytopathol; 2022 Nov; 130(11):842-843. PubMed ID: 35838629
[No Abstract] [Full Text] [Related]
38. [Progress in multi-omic study of head and neck cancer].
Wang BQ; Gao W; Wu YY
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Dec; 31(23):1785-1788;1792. PubMed ID: 29798386
[No Abstract] [Full Text] [Related]
39. Therapeutic Modalities in Head-Neck Neoplasia and Prognostication: A Review.
Munjal M; Kaur R; Kaur R; Munjal S; Chopra P; Verma H; Chopra H
Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):2445-2457. PubMed ID: 36452817
[TBL] [Abstract][Full Text] [Related]
40. Correction: Chromosome Instability Modulated by BMI1-AURKA Signaling Drives Progression in Head and Neck Cancer.
Cancer Res; 2017 Jun; 77(11):3125-3126. PubMed ID: 28572506
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
